Poster

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…

Certara2026 年 7 月 20 日

Conference

EANM 2026

–

Danielle Pillsbury2026 年 7 月 20 日

Webinar

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Hunter Stephens, PhD2026 年 7 月 17 日

Publication

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…

Certara2026 年 7 月 16 日

Blog

When to conduct hepatic impairment studies and when modeling may be enough

How to decide if a hepatic impairment study is required, choose the right study design,…

Zoe Barter2026 年 7 月 13 日

Blog

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…

Hunter Stephens, PhD2026 年 7 月 7 日

Guide

5 Key Principles of Modern PK/PD in 2026

Explore other Phoenix solutions to enhance your PK/PD workflow and discover how Phoenix helps you…

Certara2026 年 6 月 30 日

Blog

Enhancing clinical trials with real-world evidence in pregnancy research

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

Alekhya Lavu, PhD, PharmD2026 年 6 月 26 日

Announcement

Certara 推出“Bio Venture Catalyst”计划，助力新兴生物科技企业降低投资风险并加速研发进程

Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…

Danielle Pillsbury2026 年 6 月 23 日

Blog Case Study

63 次迭代仍未收敛：When RsNLME succeeded where other PK/PD solutions couldn’t

After 63 failed runs on a 16-ODE neutropenia model, RsNLME achieved PK/PD convergence on the…

Stephen Duffull2026 年 6 月 23 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

临床药理学

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

EANM 2026

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

When to conduct hepatic impairment studies and when modeling may be enough

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

5 Key Principles of Modern PK/PD in 2026

Enhancing clinical trials with real-world evidence in pregnancy research

Certara 推出“Bio Venture Catalyst”计划，助力新兴生物科技企业降低投资风险并加速研发进程

63 次迭代仍未收敛：When RsNLME succeeded where other PK/PD solutions couldn’t

订阅时事通讯

快捷链接

解决方案

联系我们